Osseon receives FDA clearance, launches steerable balloon product

 
Osseon announced U.S. Food and Drug Administration clearance and the commercial release of its Osseoflex SB 2ml steerable balloon, an addition to its articulating vertebral augmentation product line.

Advertisement

The steerable Osseoflex SB balloon can navigate with accuracy and control within the vertebra to create a central cavity across the sagittal midline.

 

Osseon focuses on developing and commercializing medical devices for minimally invasive treatment of vertebral compression fractures.

More articles on devices:

Ronda Stryker sells 14k more shares in $1M transaction
Who has clinical quality & cost-effectiveness in spine? Frost & Sullivan says Baxano
LDR COO sells 19k shares in $512k transaction

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.